Gene expression in atherogenesis

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Genetics

Background:

• Atherosclerosis pathogenesis involves complex genetic alterations in vascular and blood cells.
• Gene-environment and gene-gene interactions contribute to differential gene expression.
• Understanding these genetic changes requires advanced high-throughput technologies.

Purpose of the Study:

• To review key observations on gene expression in atherosclerosis.
• To highlight the role of specific transcription factors in disease development.
• To discuss the potential of new technologies for cardiovascular research.

Main Methods:

• Differential gene expression analysis using technologies like DD/RT-PCR, SAGE, and DNA microarrays.
• Focus on transcription factors such as nuclear factor-kappaB (NF-kappaB) and peroxisome proliferation-activating receptors (PPARs).
• Investigation of the NGFI-B subfamily of orphan receptors and the Sp/XKLF family of transcription factors.

Main Results:

• Differential expression of dozens to hundreds of genes occurs during atherosclerosis.
• NF-kappaB and PPARs play significant roles in vascular and blood cells.
• The NGFI-B subfamily is induced in neointimal smooth muscle cells.
• Sp/XKLF family members, like LKLF, are implicated in cell communication and maintaining the atherogenic phenotype.

Conclusions:

• High-throughput technologies provide crucial insights into atherogenesis.
• Knowledge of gene expression and transcription factor roles can lead to novel therapeutic strategies.
• Future treatments may involve gene therapy or drugs targeting aberrant gene expression to reverse cellular phenotypes.